Log on / register
Feedback | Support | My details

Pre-publication history

Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma

Leah M Prentice email, Christian Klausen email, Steve Kalloger email, Martin Köbel email, Steven McKinney email, Jennifer L Santos email, Challayne Kenney email, Erika Mehl email, C Blake Gilks email, Peter Leung email, Ken Swenerton email, David G Huntsman email and Samuel AJ Aparicio email

BMC Medicine 2007, 5:33doi:10.1186/1741-7015-5-33

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript01 Jun 2007
Reviewer's ReportDanny Welch25 Jun 2007
Reviewer's ReportTracey Amanda Martin26 Jun 2007
Resubmission - Version 2ManuscriptAuthors' comments24 Jul 2007
Resubmission - Version 3Manuscript24 Jul 2007
Reviewer's ReportDanny Welch17 Aug 2007
Resubmission - Version 4ManuscriptAuthors' comments21 Sep 2007
Resubmission - Version 5Manuscript26 Oct 2007
Resubmission - Version 6Manuscript26 Oct 2007
Accepted15 Nov 2007
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.